Our News Bureau – Mumbai
Biocon has inaugurated its state-of-the-art integrated research and development centre (R&D) in Bangalore by Noble Laureate Prof Kurt Wüthrich. Biocon Research Centre (BRC) is aimed at pursuing world class research on biologics that will address unmet medical needs.
BRC is a first of its kind facility in South-East Asia. The centre is also equipped with cutting edge instrumentation for extensive molecular and functional characterisation of biologics.
Prof Kurt Wüthrich said, “I am enthralled with the Biocon Research Centre’s capability which is at par with international standards. I will keenly watch the outcome of innovation from this centre as I see a lot of promise in the scientific talent at Biocon. I extend my best wishes to Biocon.”
Gracing the occasion were Prof CNR Rao, Honorary President, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCSAR); Prof P Balaram, Director Indian Institute of Science (IISc) and Prof K Vijayraghavan, Director National Centre for Biological Sciences (NCBS). Biocon has also dedicated a research wing at BRC, in honour of Rao which was also unveiled on the occasion.
Commenting on this milestone, Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon Group, said, “We aspire to build a centre of research excellence that will pursue an innovation-led effort to develop advanced yet affordable solutions for several debilitating diseases. It will epitomise Biocon’s efforts to galvanise the best talent available both in India and from across the globe, and offer them an intellectually stimulating environment combined with an enabling ecosystem to conduct path breaking research for biopharmaceuticals.”
Dr Abhijit Barve, President R&D, Biocon said, “This world class facility in India is a dream come true for any scientist and demonstrates Biocon’s commitment to world class research. This will allow cross pollination of ideas across groups that will breed a new culture of innovation and enable us to deliver on our Vision.”
A team of over 300 scientists based at BRC housed in Biocon Park, will be engaged in cutting edge Biologics research. The company aims to attract outstanding scientists from the best institutes around the world and engage with international thought leaders as well as participate in technical programmes as an effective way to enable innovation through knowledge sharing. An independent quality group at BRC will ensure compliance to Good Laboratory Practices and International regulatory guidelines for developing ‘best in class’ biologics and biosimilars. Biocon Research Centre spread across 200,000 sq. ft. will house Molecular Biology Lab; Biologics Process Science Labs; Formulations Development Lab; Molecular Characterisation Lab; Functional Bioassay Lab and Preclinical and Clinical Development Groups.
- Advertisement -
